文献速递免疫规划

应用脑膜炎奈瑟菌抗原微阵列从人类I期临床试验中鉴定候选疫苗蛋白

Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial.
PubMed 文献 · Vaccine · 2022-05-21

脑膜炎球菌性脑膜炎是一种主要影响儿童和年轻成人的罕见但严重的疾病。来自脑膜炎奈瑟菌的外膜囊泡(OMV)已被成功用作疫苗,但仅对有限数量的变体提供保护。本研究利用蛋白质抗原微阵列筛选I期临床试验中接受OMV疫苗的人类受试者血清中的IgG抗体,并通过计算方法聚类产生相似应答的抗原,发现PorA、PorB、RmpM、OpcA和PilQ等抗原与血清杀菌抗体滴度相关,提示考虑整个抗原组成可能有助于未来疫苗设计。

要点

  • OMV疫苗仅对有限数量的脑膜炎奈瑟菌变体提供保护。
  • 抗原微阵列可鉴定与血清杀菌抗体滴度相关的抗原。
  • PorA、PorB、RmpM、OpcA和PilQ为主要鉴定抗原。

核心结论

  • 考虑整个抗原组成及抗原间潜在相互作用对未来脑膜炎球菌疫苗设计可能有价值。
  • 该方法利用人类免疫数据而非动物数据,且避免筛选单个抗原。

研究设计与样本

  • 基于人类I期临床试验的血清样本,使用蛋白质抗原微阵列筛选IgG抗体。
  • 对4,005个线性回归拟合IgG抗体结合数据以识别显著相关的抗原对。
  • 使用Kendall's tau和Spearman秩相关系数统计分析血清杀菌抗体滴度与特定抗原IgG反应性的相关性。

主要发现

  • 计算方法可聚类在同一个体中引发相似应答的抗原。
  • 部分相关抗原对来自不同四级状态的同一抗原,其他可能因功能或免疫学原因相关。
  • Kendall's tau和Spearman秩相关系数均鉴定出与五种不同分离株的log(SBA)滴度相关的特定抗原。
  • 主要鉴定抗原为PorA、PorB、RmpM、OpcA和IV型菌毛组装分泌素PilQ。
  • 其他次要抗原包括一种脂蛋白、BAM复合体的两种蛋白和外排通道MtrE。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Meningococcal meningitis is a rare but serious condition affecting mainly children and young adults. Outer membrane vesicles (OMV) from Neisseria meningitidis have been used successfully as vaccines against the disease, although they only provide protection against a limited number of the many existing variants. There have been many attempts to identify suitable protein antigens for use in defined vaccines that provide broad protection against the disease, such as that leading to the development of the four component 4CMenB vaccine. We previously reported the use of a protein antigen microarray to screen for IgG antibodies in sera derived from human recipients of an OMV-based vaccine, as part of a Phase I clinical trial. Here, we show that computational methods can be used to cluster antigens that elicit similar responses in the same individuals. Fitting of IgG antibody binding data to 4,005 linear regressions identified pairs of antigens that exhibited significant correlations. Some were from the same antigens in different quaternary states, whilst others might be correlated for functional or immunological reasons. We also conducted statistical analyses to examine correlations between individual serum bactericidal antibody (SBA) titres and IgG reactivity against specific antigens. Both Kendall's tau and Spearman's rank correlation coefficient statistics identified specific antigens that correlated with log(SBA) titre in five different isolates. The principal antigens identified were PorA and PorB, RmpM, OpcA, and the type IV pilus assembly secretin, PilQ. Other minor antigens identified included a lipoprotein, two proteins from the BAM complex and the efflux channel MtrE. Our results suggest that consideration of the entire antigen composition, and allowance for potential interaction between antigens, could be valuable in designing future meningococcal vaccines. Such an approach has the advantages that it uses data derived from human, rather than animal, immunization and that it avoids the need to screen individual antigens.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Chang CM, Awanye AM, Marsay L, et al. Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial. Vaccine. 2022. PMID: 35610106. doi:10.1016/j.vaccine.2022.05.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。